Home

patrouillieren Generation Vorsicht atorvastatin diabetes risk Meilenstein Bewegung Notfall

Associations of statin use with glycaemic traits and incident type 2  diabetes - Ahmadizar - 2019 - British Journal of Clinical Pharmacology -  Wiley Online Library
Associations of statin use with glycaemic traits and incident type 2 diabetes - Ahmadizar - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library

Risk of incident diabetes among patients treated with statins: population  based study | The BMJ
Risk of incident diabetes among patients treated with statins: population based study | The BMJ

Impact of pitavastatin on new-onset diabetes mellitus compared to  atorvastatin and rosuvastatin: a distributed network analysis of 10  real-world databases | Cardiovascular Diabetology | Full Text
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text

Best statins for reducing cardiovascular risk in people with diabetes found
Best statins for reducing cardiovascular risk in people with diabetes found

Impact of pitavastatin on new-onset diabetes mellitus compared to  atorvastatin and rosuvastatin: a distributed network analysis of 10  real-world databases | Cardiovascular Diabetology | Full Text
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text

Statin patterns and associated factors in type 2 diabetes | DMSO
Statin patterns and associated factors in type 2 diabetes | DMSO

Statins and diabetes risk
Statins and diabetes risk

Statins and risk of incident diabetes: a collaborative meta-analysis of  randomised statin trials - The Lancet
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet

Statins double risk for type 2 diabetes - Diabetes Voice
Statins double risk for type 2 diabetes - Diabetes Voice

Statins and type 2 diabetes: genetic studies on target - The Lancet
Statins and type 2 diabetes: genetic studies on target - The Lancet

Insights Into Statin-Associated Diabetes: How Important is the Risk and How  Should You Counsel Your Patient? - American College of Cardiology
Insights Into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? - American College of Cardiology

Statin use and risk of developing diabetes: results from the Diabetes  Prevention Program | BMJ Open Diabetes Research & Care
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care

Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically  Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide  Observational Cohort Study | Journal of the American Heart Association
Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association

Risk of new-onset diabetes mellitus between pitavastatin vs.... | Download  Scientific Diagram
Risk of new-onset diabetes mellitus between pitavastatin vs.... | Download Scientific Diagram

Cardiovascular benefits and diabetes risks of statin therapy in primary  prevention: an analysis from the JUPITER trial - The Lancet
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial - The Lancet

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults |  AAFP
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | AAFP

Two studies address diabetes risks with statins-one good news, one so-so
Two studies address diabetes risks with statins-one good news, one so-so

Do Statins Increase the Risk of Diabetes? - The New York Times
Do Statins Increase the Risk of Diabetes? - The New York Times

Relative contributions of statin intensity, achieved low-density  lipoprotein cholesterol level, and statin therapy duration to  cardiovascular risk reduction in patients with type 2 diabetes: population  based cohort study | Cardiovascular Diabetology
Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study | Cardiovascular Diabetology

Statins and diabetes risk
Statins and diabetes risk

Statin use and risk of developing diabetes: results from the Diabetes  Prevention Program | BMJ Open Diabetes Research & Care
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care

Impact of pitavastatin on new-onset diabetes mellitus compared to  atorvastatin and rosuvastatin: a distributed network analysis of 10  real-world databases | Cardiovascular Diabetology | Full Text
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text